Dr. Polikoff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1615 Delaware St
Longview, WA 98632Phone+1 360-414-7878Fax+1 360-414-7876
Education & Training
- Albany Medical CenterResidency, Internal Medicine, 1977 - 1980
- Albany Medical CollegeClass of 1977
Certifications & Licensure
- CA State Medical License 1980 - 2026
- WA State Medical License 2020 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2008 Feb 29
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Join now to see all
Publications & Presentations
PubMed
- 211 citationsNSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by...Louis Fehrenbacher, Reena S. Cecchini, Charles E. Geyer, Priya Rastogi, Joseph P. Costantino
Journal of Clinical Oncology. 2020-02-10 - 957 citationsAddition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Pre...Eric Van Cutsem, Josep Tabernero, Radek Lakomy, Hans Prenen, Jana Prausová
Journal of Clinical Oncology. 2012-09-04 - 3339 citationsAtezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.Achim Rittmeyer, Fabrice Barlesi, Daniel Waterkamp, Keunchil Park, Fortunato Ciardiello
Lancet. 2017-01-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: